Mackenzie Financial Corp purchased a new position in shares of Steris PLC (NYSE:STE) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 190,083 shares of the medical equipment provider’s stock, valued at approximately $20,310,000.

Several other hedge funds have also modified their holdings of STE. Oregon Public Employees Retirement Fund raised its stake in shares of Steris by 10,585.0% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 3,572,743 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 3,539,306 shares in the last quarter. Enlightenment Research LLC acquired a new position in shares of Steris in the fourth quarter valued at $53,000. Rehmann Capital Advisory Group raised its stake in shares of Steris by 15.6% in the third quarter. Rehmann Capital Advisory Group now owns 712 shares of the medical equipment provider’s stock valued at $81,000 after purchasing an additional 96 shares in the last quarter. Steward Partners Investment Advisory LLC raised its stake in shares of Steris by 118.0% in the third quarter. Steward Partners Investment Advisory LLC now owns 909 shares of the medical equipment provider’s stock valued at $104,000 after purchasing an additional 492 shares in the last quarter. Finally, First Hawaiian Bank acquired a new position in shares of Steris in the third quarter valued at $106,000. Institutional investors own 91.81% of the company’s stock.

A number of analysts have weighed in on STE shares. Sidoti upped their price target on Steris from $155.00 to $157.00 and gave the company a “buy” rating in a research report on Thursday, December 6th. Zacks Investment Research reiterated a “buy” rating and issued a $132.00 price target on shares of Steris in a research report on Friday, November 16th. JMP Securities reiterated a “buy” rating and issued a $135.00 price target on shares of Steris in a research report on Thursday, February 14th. Stephens reiterated a “buy” rating and issued a $135.00 price target on shares of Steris in a research report on Thursday, February 14th. Finally, KeyCorp upped their price target on Steris from $120.00 to $132.00 and gave the company an “overweight” rating in a research report on Tuesday, November 13th. Five research analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and a consensus target price of $138.20.

In other news, VP John Adam Zangerle sold 1,750 shares of the stock in a transaction on Friday, January 11th. The stock was sold at an average price of $110.00, for a total transaction of $192,500.00. Following the sale, the vice president now owns 32,546 shares in the company, valued at $3,580,060. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.38% of the stock is currently owned by corporate insiders.

Shares of NYSE:STE opened at $122.28 on Tuesday. Steris PLC has a fifty-two week low of $88.81 and a fifty-two week high of $123.50. The firm has a market capitalization of $10.34 billion, a price-to-earnings ratio of 29.47 and a beta of 1.04. The company has a current ratio of 2.56, a quick ratio of 2.01 and a debt-to-equity ratio of 0.40.

Steris (NYSE:STE) last announced its quarterly earnings results on Monday, February 11th. The medical equipment provider reported $1.26 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.26. Steris had a return on equity of 12.50% and a net margin of 9.85%. The firm had revenue of $696.24 million for the quarter, compared to analysts’ expectations of $687.90 million. As a group, research analysts predict that Steris PLC will post 4.78 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 21st. Stockholders of record on Wednesday, February 27th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.11%. The ex-dividend date of this dividend is Tuesday, February 26th. Steris’s payout ratio is presently 32.77%.

WARNING: This report was first posted by Daily Political and is owned by of Daily Political. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.dailypolitical.com/2019/02/19/mackenzie-financial-corp-purchases-shares-of-190083-steris-plc-ste.html.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Read More: How to calculate the annual rate of depreciation

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.